Antimicrobial Resistance of Escherichia coli for Uncomplicated Cystitis: Korean Antimicrobial Resistance Monitoring System · Yu SH, Jung SI, Lee SJ et al.
References
- Flores-MirelesA.L. WalkerJ.N. CaparonM. HultgrenS.J. Urinary tract infections: Epidemiology, mechanisms of infection and treatment optionsNat. Rev. Microbiol.20151326928410.1038/nrmicro343225853778PMC4457377
- FoxmanB. Urinary tract infection syndromes: Occurrence, recurrence, bacteriology, risk factors, and disease burdenInfect. Dis. Clin. N. Am.20142811310.1016/j.idc.2013.09.00324484571
- HootonT.M. Clinical practice. Uncomplicated urinary tract infectionN. Engl. J. Med.20123661028103710.1056/NEJMcp110442922417256
- BonkatG. BruyèreR.B.F. CaiT. GeerlingsS.E. KövesB. KranzJ. SchubertS. PilatzA. VeeratterapillayR. WagenlehnerF. EAU Guidelines on Urological InfectionsEur. Assoc. Urol.202418222610.1016/j.eururo.2024.03.03538714379
- FoxmanB. Epidemiology of urinary tract infections: Incidence, morbidity, and economic costsDis. Mon.200349537010.1067/mda.2003.712601337
- WagenlehnerF.M. HoymeU. KaaseM. FunfstuckR. NaberK.G. SchmiemannG. Uncomplicated urinary tract infectionsDtsch. Aerzteblatt Online201110841542310.3238/arztebl.2011.041521776311PMC3132618
- AngerJ. LeeU. AckermanA.L. ChouR. ChughtaiB. ClemensJ.Q. HicklingD. KapoorA. KentonK.S. KaufmanM.R. Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU GuidelineJ. Urol.201920228228910.1097/JU.000000000000029631042112
- NaberK.G. Tiran-SaucedoJ. WagenlehnerF.M.E. GroupR. Psychosocial burden of recurrent uncomplicated urinary tract infectionsGMS Infect. Dis.202210Doc0110.3205/id00007835463815PMC9006425
- ZhouY. ZhouZ. ZhengL. GongZ. LiY. JinY. HuangY. ChiM. Urinary Tract Infections Caused by Uropathogenic Escherichia coli: Mechanisms of Infection and Treatment OptionsInt. J. Mol. Sci.2023241053710.3390/ijms24131053737445714PMC10341809
- WhelanS. LuceyB. FinnK. Uropathogenic Escherichia coli (UPEC)-Associated Urinary Tract Infections: The Molecular Basis for Challenges to Effective TreatmentMicroorganisms202311216910.3390/microorganisms1109216937764013PMC10537683
- AlghamdiS.A.A. MirS.S. AlghamdiF.S. Al BanghaliM. AlmalkiS.S.R. Evaluation of Extended-Spectrum Beta-Lactamase Resistance in Uropathogenic Escherichia coli Isolates from Urinary Tract Infection Patients in Al-Baha, Saudi ArabiaMicroorganisms202311282010.3390/microorganisms1112282038137964PMC10745543
- AdedejiW.A. The Treasure Called AntibioticsAnn. Ib. Postgrad. Med.201614565728337088PMC5354621
- NathanC. Antibiotics at the crossroadsNature200443189990210.1038/431899a15496893
- LingW. Furuya-KanamoriL. EzureY. HarrisP.N.A. PatersonD.L. Adverse clinical outcomes associated with infections by Enterobacterales producing ESBL (ESBL-E): A systematic review and meta-analysisJAC Antimicrob. Resist.20213dlab06810.1093/jacamr/dlab06835233528PMC8210200
- AslamB. WangW. ArshadM.I. KhurshidM. MuzammilS. RasoolM.H. NisarM.A. AlviR.F. AslamM.A. QamarM.U. Antibiotic resistance: A rundown of a global crisisInfect. Drug Resist.2018111645165810.2147/IDR.S17386730349322PMC6188119
- CekM. TandogduZ. WagenlehnerF. TenkeP. NaberK. Bjerklund-JohansenT.E. Healthcare-associated urinary tract infections in hospitalized urological patients--a global perspective: Results from the GPIU studies 2003–2010World J. Urol.2014321587159410.1007/s00345-013-1218-924452449
- JerniganJ.A. HatfieldK.M. WolfordH. NelsonR.E. OlubajoB. ReddyS.C. McCarthyN. PaulP. McDonaldL.C. KallenA. Multidrug-Resistant Bacterial Infections in U.S. Hospitalized Patients, 2012–2017N. Engl. J. Med.20203821309131910.1056/NEJMoa191443332242356PMC10961699
- MichaelC.A. Dominey-HowesD. LabbateM. The antimicrobial resistance crisis: Causes, consequences, and managementFront. Public Health2014214510.3389/fpubh.2014.0014525279369PMC4165128
- SpellbergB. SrinivasanA. ChambersH.F. New Societal Approaches to Empowering Antibiotic StewardshipJAMA20163151229123010.1001/jama.2016.134626914942PMC5611826
- WagenlehnerF. TandogduZ. BartolettiR. CaiT. CekM. KulchavenyaE. KovesB. NaberK. PerepanovaT. TenkeP. The Global Prevalence of Infections in Urology (GPUI) Study: A Worldwide Surveillance Study in Urology PatientsEur. Urol. Focus2016234534710.1016/j.euf.2016.03.00428723463
- LeeS.J. LeeD.S. ChoeH.S. ShimB.S. KimC.S. KimM.E. ChoY.H. Antimicrobial resistance in community-acquired urinary tract infections: Results from the Korean Antimicrobial Resistance Monitoring SystemJ. Infect. Chemother.20111744044610.1007/s10156-011-0248-821140281
- WadaK. TsuboiI. TakahashiS. YasudaM. MiyazakiJ. KobayashiK. MatsumotoM. HayamiH. YamamotoS. KiyotaH. Third nationwide surveillance of bacterial pathogens in patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2020 and 2021: Antimicrobial susceptibility of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus saprophyticusJ. Infect. Chemother.20243027728510.1016/j.jiac.2024.01.01138242285
- KaraA. MassaroC. GiammancoG.M. AlduinaR. BoussoualimN. Phylogenetic Diversity, Antibiotic Resistance, and Virulence of Escherichia coli Strains from Urinary Tract Infections in AlgeriaAntibiotics20241377310.3390/antibiotics1308077339200073PMC11350822
- KotB. Antibiotic Resistance Among Uropathogenic Escherichia coliPol. J. Microbiol.20196840341510.33073/pjm-2019-04831880885PMC7260639
- ChoiU. KimE. LyuD.H. KimK.S. ParkB.H. ChungH. HanC.H. BaeS. The change of antibiotic susceptibility in febrile urinary tract infection in childhood and adolescence during the last decadeInvestig. Clin. Urol.2022639910610.4111/icu.20210350PMC875614634983128
- WadaK. YokoyamaT. UnoS. ArakiM. SadahiraT. MaruyamaY. AcostaH. NakajimaH. HiyamaY. KunishimaY. Nationwide surveillance of bacterial pathogens isolated from patients with acute uncomplicated cystitis in 2018: Conducted by the Japanese Research Group for Urinary Tract Infections (JRGU)J. Infect. Chemother.2021271169118010.1016/j.jiac.2021.03.01233863634
- TerlizziM.E. GribaudoG. MaffeiM.E. UroPathogenic Escherichia coli (UPEC) Infections: Virulence Factors, Bladder Responses, Antibiotic, and Non-antibiotic Antimicrobial StrategiesFront. Microbiol.20178156610.3389/fmicb.2017.0156628861072PMC5559502
- DhakalB.K. KulesusR.R. MulveyM.A. Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coliEur. J. Clin. Investig.200838(Suppl. S2)21110.1111/j.1365-2362.2008.01986.x18616559
- KostakiotiM. HultgrenS.J. HadjifrangiskouM. Molecular blueprint of uropathogenic Escherichia coli virulence provides clues toward the development of anti-virulence therapeuticsVirulence2012359259410.4161/viru.2236423154288PMC3545937
- HadidiM.F. AlhamamiN. AlhakamiM. AbdulhamidA.S. AlsharifA. AlomariM.S. AlghamdiY.A. AlshehriS. GhaddafA.A. AlsenaniF.M. Antibiotics efficacy in clinical and microbiological cure of uncomplicated urinary tract infection: A systematic review and network meta-analysisWorld J. Urol.20244222110.1007/s00345-024-04922-538587648
- JungC. BrubakerL. The etiology and management of recurrent urinary tract infections in postmenopausal womenClimacteric20192224224910.1080/13697137.2018.155187130624087PMC6629580
- CastanheiraM. SimnerP.J. BradfordP.A. Extended-spectrum beta-lactamases: An update on their characteristics, epidemiology and detectionJAC Antimicrob. Resist.20213dlab09210.1093/jacamr/dlab09234286272PMC8284625
- BaeS. Practice Pattern Survey I: Analysis Study on the Actual Clinical Practices for Cystitis Treatment2024 KUA Abstr.2024359EP-015Available online: https://www.urology.or.kr/abstract/2024_fall/file/KUA_2024_Abstract_book_241011_1.pdf?v=1(accessed on 5 November 2024)
- DellitT.H. OwensR.C. McGowanJ.E.Jr. GerdingD.N. WeinsteinR.A. BurkeJ.P. HuskinsW.C. PatersonD.L. FishmanN.O. CarpenterC.F. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardshipClin. Infect. Dis.20074415917710.1086/51039317173212
- SchutsE.C. HulscherM. MoutonJ.W. VerduinC.M. StuartJ. OverdiekH. van der LindenP.D. NatschS. HertoghC. WolfsT.F.W. Current evidence on hospital antimicrobial stewardship objectives: A systematic review and meta-analysisLancet Infect. Dis.20161684785610.1016/S1473-3099(16)00065-726947617
- HumphriesR.M. AbbottA.N. HindlerJ.A. Understanding and Addressing CLSI Breakpoint Revisions: A Primer for Clinical LaboratoriesJ. Clin. Microbiol.20195710-112810.1128/JCM.00203-19PMC653559530971460
- WeinsteinM.P. LewisJ.S.2nd The Clinical and Laboratory Standards Institute Subcommittee on Antimicrobial Susceptibility Testing: Background, Organization, Functions, and ProcessesJ. Clin. Microbiol.20205810-112810.1128/JCM.01864-19PMC704157631915289
- KahlmeterG. GiskeC.G. KirnT.J. SharpS.E. Point-Counterpoint: Differences between the European Committee on Antimicrobial Susceptibility Testing and Clinical and Laboratory Standards Institute Recommendations for Reporting Antimicrobial Susceptibility ResultsJ. Clin. Microbiol.20195710-112810.1128/JCM.01129-19PMC671192231315957
CC BY 4.0. "Antimicrobial Resistance of Escherichia coli for Uncomplicated Cystitis: Korean Antimicrobial Resistance Monitoring System" by Yu SH, Jung SI, Lee SJ et al., Antibiotics (Basel, Switzerland) (2024). https://doi.org/10.3390/antibiotics13111075. Licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Peer-reviewed and open access; full text from PubMed Central (PMC11591001). Headings and layout adapted for reading; figures and tables are in the original.